Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

OTLK Outlook Therapeutics Inc

8.30

0.13 (1.59%)

Last Updated: 13:24:32

Delayed by 15 minutes

Outlook Therapeutics files for FDA approval of ONS-5010 for eye disorder

To read the full story on Seeking Alpha, click here.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Outlook Therapeutics Charts.

Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Outlook Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Outlook Therapeutics Inc News

More Outlook Therapeutics Inc News Articles

Net Savings Link (PK)

Branded Legacy (PK)

Revance Therapeutics

Clean Vision (QB)

Hannover House (PK)

1812 Brewing (PK)

Voip Pal Com (QB)

Good Vibrations Shoes (PK)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock